查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2135464

副流感病毒快速檢測套組市場－全球預測（2026-2032年）

Parainfluenza Virus Rapid Test Kits Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，副流感病毒快速檢測套組市場將成長至 6.0426 億美元，複合年成長率為 10.84%。

主要市場統計數據
基準年 2025 2.9388億美元
預計年份：2026年 3.3267億美元
預測年份 2032 6.0426億美元
複合年成長率 (%) 10.84%

副流感病毒快速檢測套組有助於檢測人類副流感病毒引起的呼吸道感染疾病。這些感染疾病可導致多種疾病，從輕微的上呼吸道症狀到哮吼、毛細支氣管炎和肺炎。當臨床醫師需要快速鑑別呼吸道病原體時，此檢測套組的價值尤其突出，尤其是在小兒科、醫院、急診和疫情應變等環境中。在解讀檢測結果時，應考慮檢體品質、採集時間、檢測方法效能以及在高臨床風險病例中是否需要進行分子檢測以確診。

呼吸系統疾病的診斷正朝著更快、更全面的檢測方向發展。

該領域的格局正因對快速臨床決策、多參數呼吸道檢測、分散式檢查、更嚴格的感染控制方案以及加強季節性呼吸道疾病監測的需求而發生重塑。醫療系統也日益重視工作流程效率、標準化品管以及可在急診、門診、檢查室和公共衛生等不同場所進行的檢測。實施過程仍然受到保險報銷、採購規則、監管要求、操作人員培訓以及抗原診斷和分子診斷相對表現的影響。

人工智慧可以提升判斷力和診斷流程。

人工智慧 (AI) 可以透過改進分流、基於症狀的風險評估、影像和訊號解讀、檢查室工作流程管理以及將檢測結果與電子健康記錄整合，間接支援副流感病毒檢測。機器學習系統也有助於識別季節性模式和確定確診檢測的優先級，但其效用取決於代表性的訓練資料、透明的檢驗、網路安全和人工監督。人工智慧應作為分析檢驗和臨床醫生判斷的補充，而非替代，尤其是在易感患者或出現非典型症狀的患者中。

區域洞察：醫療服務取得差異和不同的醫療衛生系統優先事項

在北美，已建立的呼吸系統疾病監測體系、先進的檢查室基礎設施和廣泛的分子診斷服務普遍被利用，但由於採購和報銷機制的限制，這些技術在常規臨床實踐中的應用受到限制。在歐洲，強大的公共衛生網路與各國特有的採購和法律規範並存。在亞太地區，分散式、較簡單的檢測方式與高效的都市區系統結合，成為更現實的選擇。拉丁美洲仍在努力平衡診斷服務的可及性、對進口的依賴以及檢測能力的不平衡。在中東，大型醫院網路、人群保健和旅行相關篩檢領域對檢測的需求強勁；而在非洲，由於基礎設施、供應鏈、人力資源和經濟方面的嚴重限制，高效便捷的檢測方式尤為重要。

群體特定洞察：貿易集團和聯盟影響診斷工具的採用

在東協市場，由於管理體制和醫療體係能力各異，靈活的分銷管道、現場培訓和可靠的供應至關重要。金磚國家成員國的醫療環境差異顯著，從已開發地區到資源匱乏地區不等，因此價格可負擔性、國內生產和公共部門採購成為關鍵考量。歐盟強調通用的監管標準，同時也承認各國在報銷和實施方法上的差異。七國集團（G7）的醫療體系通常優先考慮分析績效、證據品質、互通性和管理。海灣合作理事會（GCC）國家通常將集中採購系統與設備完善的醫院相結合，而北約成員國則可能更加重視具有韌性的供應鏈、緊急準備和緊急情況下的診斷連續性。

各國情況：國家情勢決定檢測重點

澳洲和加拿大優先考慮地域公平的醫療服務取得和綜合公共衛生監測。巴西、墨西哥、印度和南非必須應對區域差異、採購複雜性和檢查室能力等挑戰，同時還要服務龐大且多元化的人口。中國和俄羅斯擁有強大的國內醫療保健和製造能力，其部署受到各自監管和採購框架的影響。日本和韓國通常優先考慮品質保證、先進的醫院工作流程和快速的臨床決策。法國、德國、義大利、西班牙和英國的呼吸系統醫療保健體系成熟，實證醫學、保險報銷、檢查室網路和監管合規性影響著醫療服務的部署。美國則高度重視臨床效用、法規核准、分散式檢查以及與複雜的醫療服務網路的整合。

呼吸系統診斷領域領導者應優先考慮的問題

領導者檢驗試劑盒對臨床相關檢體和流行性呼吸道疾病的適用性，明確其預期用途，並公佈涵蓋不同年齡層和症狀持續時間的透明性能數據。他們還應加強品管系統、批次間一致性、操作人員培訓、外部品質評估和上市後監測。產品策略應支援互通性、便捷的檢體採集、清晰的結果解讀和供應保障。與醫院、實驗室、兒童醫療服務機構和公共衛生機構的合作應有助於推廣應用，而負責任的人工智慧管治應包括偏差測試、可解釋性、網路安全和臨床醫生課責。

評估診斷狀態的調查方法

嚴謹的評估應整契約儕審查的臨床證據、監管和檢查室指南、公共衛生監測、診斷性能研究、採購文件以及醫療保健系統實施的文獻。評估結果應從多個角度進行檢驗，涵蓋不同的檢測形式、檢體類型、患者群體、醫療機構和地區。分析應區分分析靈敏度和特異性與實際臨床效用，明確指出限制和證據不足之處，並避免從無關的呼吸道病原體推斷檢測性能。區域間和國際間的比較應考慮基礎設施、法規、保險報銷、醫療專業人員、流行病學和供應鏈狀況。

結論：可靠的取得途徑和證據決定臨床價值。

快速副流感病毒檢測套組若結果準確、易於臨床解讀並整合到合適的診療路徑中，則有助於快速評估呼吸道症狀。其實際應用價值更取決於檢體品質、檢測有效性、工作流程相容性、經濟性和可近性，而非檢測速度本身。將可靠的實證醫學證據與完善的交付系統、負責任的數位整合以及在地化部署相結合的行業領導企業，將更有利於為臨床醫生和公共衛生計畫提供支援。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 副流感病毒快速檢測套組市場：依檢測方法分類

  • 基於設備的檢查
    • 化學冷光免疫檢測
    • 螢光免疫分析
  • 無需任何設備
    • 凝血法
    • 側向流動免疫檢測

第8章 副流感病毒快速檢測套組市場：依樣本類型分類

  • 鼻拭子
  • 鼻咽拭子
  • 口腔和咽拭子
  • 唾液

第9章 副流感病毒快速檢測套組市場：依最終用戶分類

  • 臨床實驗室
  • 居家醫療
  • 醫院實驗室
  • 即時檢測中心

第10章：副流感病毒快速檢測套組市場：依分銷管道分類

  • 直接向家庭銷售
  • 醫院採購
  • 線上
  • 藥局

第11章 副流感病毒快速檢測套組市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章 副流感病毒快速檢測套組市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：副流感病毒快速檢測套組市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Abbott Laboratories
  • Abingdon Health Ltd
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories Inc
  • Cepheid
  • Danaher Corporation
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd
  • GenMark Diagnostics Inc
  • Hologic Inc
  • Luminex Corporation
  • Meridian Bioscience Inc
  • QIAGEN NV
  • Quidel Corporation
  • Seegene Inc
  • Thermo Fisher Scientific Inc

第16章 主要專家

Product Code: MRR-961F26FD645A

The Parainfluenza Virus Rapid Test Kits Market is projected to grow by USD 604.26 million at a CAGR of 10.84% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 293.88 million
Estimated Year [2026] USD 332.67 million
Forecast Year [2032] USD 604.26 million
CAGR (%) 10.84%

Parainfluenza virus rapid test kits support the detection of respiratory infections caused by human parainfluenza viruses, which are associated with illnesses ranging from mild upper-respiratory symptoms to croup, bronchiolitis, and pneumonia. Their value is greatest where clinicians need timely differentiation of respiratory pathogens, particularly in pediatric, hospital, urgent-care, and outbreak-response settings. Interpretation should account for specimen quality, timing of collection, assay performance, and the need for confirmatory molecular testing when clinical risk is high.

Respiratory Diagnostics Are Shifting Toward Faster, Integrated Testing

The landscape is being reshaped by demand for rapid clinical decisions, multiplex respiratory panels, decentralized testing, stronger infection-control protocols, and improved surveillance of seasonal respiratory disease. Health systems are also emphasizing workflow efficiency, standardized quality management, and tests that can operate across emergency, outpatient, laboratory, and public-health environments. Adoption remains influenced by reimbursement, procurement rules, regulatory requirements, operator training, and the relative performance of antigen-based and molecular methods.

Artificial Intelligence Strengthens Interpretation and Diagnostic Workflows

Artificial intelligence can support parainfluenza testing indirectly by improving triage, symptom-based risk assessment, image or signal interpretation, laboratory workflow management, and integration of results with electronic health records. Machine-learning systems may also help identify seasonal patterns and prioritize confirmatory testing, but their usefulness depends on representative training data, transparent validation, cybersecurity, and human oversight. AI should complement, rather than replace, analytical validation and clinician judgment, especially for vulnerable patients and atypical presentations.

Regional Insights: Uneven Access and Distinct Health-System Priorities

North America generally benefits from established respiratory surveillance, advanced laboratory infrastructure, and broad access to molecular diagnostics, while procurement and reimbursement shape use in routine care. Europe combines strong public-health networks with varied national purchasing and regulatory pathways. Asia-Pacific includes highly capable urban systems alongside settings where decentralized and lower-complexity testing is more practical. Latin America continues to balance diagnostic access, import dependence, and uneven laboratory capacity. The Middle East shows strong demand in major hospital networks and during congregate-care or travel-related screening scenarios, while Africa faces substantial infrastructure, supply-chain, workforce, and affordability constraints that make robust, easy-to-use tests especially important.

Group Insights: Trade Blocs and Alliances Shape Diagnostic Deployment

ASEAN markets reflect varied regulatory systems and health-system capacity, creating a need for adaptable distribution, local training, and reliable supply. BRICS members span advanced and resource-constrained environments, making affordability, domestic production, and public-sector procurement important considerations. The European Union emphasizes common regulatory expectations while retaining national differences in reimbursement and implementation. G7 health systems typically prioritize analytical performance, evidence quality, interoperability, and stewardship. GCC countries often combine centralized procurement with well-resourced hospitals, whereas NATO members may additionally value resilient supply chains, preparedness, and continuity of diagnostics during emergencies.

Country Insights: National Context Determines Testing Priorities

Australia and Canada emphasize geographically equitable access and integrated public-health surveillance. Brazil, Mexico, India, and South Africa must address regional disparities, procurement complexity, and laboratory capacity while supporting large and diverse populations. China and Russia have substantial domestic healthcare and manufacturing capabilities, with implementation shaped by national regulatory and procurement frameworks. Japan and South Korea generally prioritize quality assurance, advanced hospital workflows, and rapid clinical decision-making. France, Germany, Italy, Spain, and the United Kingdom operate within mature respiratory-care systems where evidence, reimbursement, laboratory networks, and regulatory compliance influence uptake. The United States places strong emphasis on clinical utility, regulatory authorization, decentralized testing, and integration with complex provider networks.

Actionable Priorities for Leaders in Respiratory Diagnostics

Leaders should validate kits against clinically relevant specimens and circulating respiratory conditions, clearly define intended-use settings, and publish transparent performance data across age groups and symptom durations. They should strengthen quality systems, lot consistency, operator training, external quality assessment, and post-market surveillance. Product strategies should support interoperability, practical sample collection, clear result interpretation, and supply resilience. Partnerships with hospitals, laboratories, pediatric services, and public-health agencies can improve implementation, while responsible AI governance should include bias testing, explainability, cybersecurity, and clinician accountability.

Research Methodology for Assessing the Diagnostic Landscape

A rigorous assessment combines peer-reviewed clinical evidence, regulatory and laboratory guidance, public-health surveillance, diagnostic-performance studies, procurement documentation, and health-system implementation literature. Findings should be triangulated across assay formats, specimen types, patient populations, care settings, and geographies. The analysis should distinguish analytical sensitivity and specificity from real-world clinical utility, document limitations and evidence gaps, and avoid inferring performance from unrelated respiratory pathogens. Regional and country comparisons should consider infrastructure, regulation, reimbursement, workforce, epidemiology, and supply-chain conditions.

Conclusion: Reliable Access and Evidence Will Define Clinical Value

Parainfluenza virus rapid test kits can contribute to faster respiratory assessment when their results are accurate, clinically interpretable, and embedded in appropriate care pathways. Their practical impact depends less on speed alone than on specimen quality, assay validation, workflow fit, affordability, and access to confirmatory testing. Industry leaders that combine robust evidence with resilient delivery, responsible digital integration, and regionally appropriate implementation will be better positioned to support clinicians and public-health programs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Parainfluenza Virus Rapid Test Kits Market, by Test Method

  • 7.1. Introduction
  • 7.2. Instrument Based
    • 7.2.1. Chemiluminescence Immunoassay
    • 7.2.2. Fluorescence Immunoassay
  • 7.3. Instrument Free
    • 7.3.1. Agglutination Assay
    • 7.3.2. Lateral Flow Immunoassay

8. Parainfluenza Virus Rapid Test Kits Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Nasal Swab
  • 8.3. Nasopharyngeal Swab
  • 8.4. Oropharyngeal Swab
  • 8.5. Saliva

9. Parainfluenza Virus Rapid Test Kits Market, by End User

  • 9.1. Introduction
  • 9.2. Clinical Laboratories
  • 9.3. Home Care Settings
  • 9.4. Hospital Laboratories
  • 9.5. Point Of Care Testing Centers

10. Parainfluenza Virus Rapid Test Kits Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Direct To Home
  • 10.3. Hospital Procurement
  • 10.4. Online
  • 10.5. Pharmacy

11. Parainfluenza Virus Rapid Test Kits Market, by Region

  • 11.1. Introduction
  • 11.2. Asia-Pacific
  • 11.3. North America
  • 11.4. Latin America
  • 11.5. Europe
  • 11.6. Middle East
  • 11.7. Africa

12. Parainfluenza Virus Rapid Test Kits Market, by Group

  • 12.1. Introduction
  • 12.2. ASEAN
  • 12.3. GCC
  • 12.4. European Union
  • 12.5. BRICS
  • 12.6. G7
  • 12.7. NATO

13. Parainfluenza Virus Rapid Test Kits Market, by Country

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. United Kingdom
  • 13.7. Germany
  • 13.8. France
  • 13.9. Russia
  • 13.10. Italy
  • 13.11. Spain
  • 13.12. China
  • 13.13. India
  • 13.14. Japan
  • 13.15. Australia
  • 13.16. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. Market Concentration Analysis, 2025
    • 14.2.1. Concentration Ratio (CR)
    • 14.2.2. Herfindahl Hirschman Index (HHI)
  • 14.3. Recent Developments & Impact Analysis, 2025
  • 14.4. Product Portfolio Analysis, 2025
  • 14.5. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Abbott Laboratories
  • 15.2. Abingdon Health Ltd
  • 15.3. Becton, Dickinson and Company
  • 15.4. bioMerieux SA
  • 15.5. Bio-Rad Laboratories Inc
  • 15.6. Cepheid
  • 15.7. Danaher Corporation
  • 15.8. DiaSorin S.p.A
  • 15.9. F. Hoffmann-La Roche Ltd
  • 15.10. GenMark Diagnostics Inc
  • 15.11. Hologic Inc
  • 15.12. Luminex Corporation
  • 15.13. Meridian Bioscience Inc
  • 15.14. QIAGEN N.V
  • 15.15. Quidel Corporation
  • 15.16. Seegene Inc
  • 15.17. Thermo Fisher Scientific Inc

16. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Parainfluenza Virus Rapid Test Kits Market, Years Considered for the Study
  • FIGURE 2. Global Parainfluenza Virus Rapid Test Kits Market, Research Design
  • FIGURE 3. Global Parainfluenza Virus Rapid Test Kits Market, Research Framework
  • FIGURE 4. Global Parainfluenza Virus Rapid Test Kits Market, Data Triangulation
  • FIGURE 5. Global Parainfluenza Virus Rapid Test Kits Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2025 vs 2032 (%)
  • FIGURE 7. Global Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2025 vs 2032 (%)
  • FIGURE 9. Global Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 11. Global Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 13. Global Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Parainfluenza Virus Rapid Test Kits Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 15. Global Parainfluenza Virus Rapid Test Kits Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Parainfluenza Virus Rapid Test Kits Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 17. Global Parainfluenza Virus Rapid Test Kits Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 18. Global Parainfluenza Virus Rapid Test Kits Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Parainfluenza Virus Rapid Test Kits Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Parainfluenza Virus Rapid Test Kits Market Segmentation & Coverage
  • TABLE 2. Global Parainfluenza Virus Rapid Test Kits Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 4. Global Instrument Based Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Instrument Based Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Instrument Based Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Chemiluminescence Immunoassay Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Chemiluminescence Immunoassay Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Chemiluminescence Immunoassay Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Fluorescence Immunoassay Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Fluorescence Immunoassay Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Fluorescence Immunoassay Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Instrument Free Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Instrument Free Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Instrument Free Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Agglutination Assay Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Agglutination Assay Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Agglutination Assay Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Lateral Flow Immunoassay Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Lateral Flow Immunoassay Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Lateral Flow Immunoassay Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 23. Global Nasal Swab Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Nasal Swab Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Nasal Swab Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Nasopharyngeal Swab Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 27. Global Nasopharyngeal Swab Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 28. Global Nasopharyngeal Swab Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 29. Global Oropharyngeal Swab Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 30. Global Oropharyngeal Swab Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 31. Global Oropharyngeal Swab Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 32. Global Saliva Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 33. Global Saliva Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 34. Global Saliva Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 35. Global Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 36. Global Clinical Laboratories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 37. Global Clinical Laboratories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 38. Global Clinical Laboratories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 39. Global Home Care Settings Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 40. Global Home Care Settings Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 41. Global Home Care Settings Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 42. Global Hospital Laboratories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 43. Global Hospital Laboratories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 44. Global Hospital Laboratories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 45. Global Point Of Care Testing Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 46. Global Point Of Care Testing Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 47. Global Point Of Care Testing Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 48. Global Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 49. Global Direct To Home Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Direct To Home Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Direct To Home Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Hospital Procurement Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 53. Global Hospital Procurement Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 54. Global Hospital Procurement Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 55. Global Online Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 56. Global Online Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 57. Global Online Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 58. Global Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 59. Global Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 60. Global Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 61. Global Parainfluenza Virus Rapid Test Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Asia-Pacific Parainfluenza Virus Rapid Test Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Asia-Pacific Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 64. Asia-Pacific Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 65. Asia-Pacific Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 66. Asia-Pacific Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 67. Asia-Pacific Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 68. Asia-Pacific Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 69. North America Parainfluenza Virus Rapid Test Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. North America Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 71. North America Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 72. North America Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 73. North America Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 74. North America Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 75. North America Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 76. Latin America Parainfluenza Virus Rapid Test Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 77. Latin America Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 78. Latin America Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 79. Latin America Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 80. Latin America Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 81. Latin America Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 82. Latin America Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 83. Europe Parainfluenza Virus Rapid Test Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 84. Europe Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 85. Europe Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 86. Europe Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 87. Europe Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 88. Europe Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 89. Europe Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 90. Middle East Parainfluenza Virus Rapid Test Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 91. Middle East Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 92. Middle East Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 93. Middle East Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 94. Middle East Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 95. Middle East Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 96. Middle East Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 97. Africa Parainfluenza Virus Rapid Test Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 98. Africa Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 99. Africa Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 100. Africa Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 101. Africa Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 102. Africa Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 103. Africa Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 104. Global Parainfluenza Virus Rapid Test Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 105. ASEAN Parainfluenza Virus Rapid Test Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 106. ASEAN Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 107. ASEAN Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 108. ASEAN Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 109. ASEAN Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 110. ASEAN Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 111. ASEAN Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 112. GCC Parainfluenza Virus Rapid Test Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 113. GCC Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 114. GCC Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 115. GCC Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 116. GCC Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 117. GCC Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 118. GCC Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 119. European Union Parainfluenza Virus Rapid Test Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 120. European Union Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 121. European Union Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 122. European Union Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 123. European Union Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 124. European Union Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 125. European Union Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 126. BRICS Parainfluenza Virus Rapid Test Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 127. BRICS Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 128. BRICS Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 129. BRICS Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 130. BRICS Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 131. BRICS Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 132. BRICS Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 133. G7 Parainfluenza Virus Rapid Test Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 134. G7 Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 135. G7 Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 136. G7 Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 137. G7 Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 138. G7 Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 139. G7 Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 140. NATO Parainfluenza Virus Rapid Test Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 141. NATO Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 142. NATO Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 143. NATO Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 144. NATO Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 145. NATO Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 146. NATO Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 147. Global Parainfluenza Virus Rapid Test Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 148. United States Parainfluenza Virus Rapid Test Kits Market Size, 2017-2032 (USD Million)
  • TABLE 149. United States Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 150. United States Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 151. United States Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 152. United States Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 153. United States Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 154. United States Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 155. Canada Parainfluenza Virus Rapid Test Kits Market Size, 2017-2032 (USD Million)
  • TABLE 156. Canada Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 157. Canada Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 158. Canada Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 159. Canada Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 160. Canada Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 161. Canada Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 162. Mexico Parainfluenza Virus Rapid Test Kits Market Size, 2017-2032 (USD Million)
  • TABLE 163. Mexico Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 164. Mexico Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 165. Mexico Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 166. Mexico Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 167. Mexico Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 168. Mexico Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 169. Brazil Parainfluenza Virus Rapid Test Kits Market Size, 2017-2032 (USD Million)
  • TABLE 170. Brazil Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 171. Brazil Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 172. Brazil Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 173. Brazil Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 174. Brazil Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 175. Brazil Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 176. United Kingdom Parainfluenza Virus Rapid Test Kits Market Size, 2017-2032 (USD Million)
  • TABLE 177. United Kingdom Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 178. United Kingdom Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 179. United Kingdom Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 180. United Kingdom Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 181. United Kingdom Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 182. United Kingdom Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 183. Germany Parainfluenza Virus Rapid Test Kits Market Size, 2017-2032 (USD Million)
  • TABLE 184. Germany Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 185. Germany Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 186. Germany Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 187. Germany Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 188. Germany Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 189. Germany Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 190. France Parainfluenza Virus Rapid Test Kits Market Size, 2017-2032 (USD Million)
  • TABLE 191. France Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 192. France Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 193. France Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 194. France Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 195. France Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 196. France Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 197. Russia Parainfluenza Virus Rapid Test Kits Market Size, 2017-2032 (USD Million)
  • TABLE 198. Russia Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 199. Russia Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 200. Russia Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 201. Russia Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 202. Russia Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 203. Russia Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 204. Italy Parainfluenza Virus Rapid Test Kits Market Size, 2017-2032 (USD Million)
  • TABLE 205. Italy Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 206. Italy Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 207. Italy Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 208. Italy Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 209. Italy Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 210. Italy Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 211. Spain Parainfluenza Virus Rapid Test Kits Market Size, 2017-2032 (USD Million)
  • TABLE 212. Spain Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 213. Spain Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 214. Spain Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 215. Spain Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 216. Spain Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 217. Spain Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 218. China Parainfluenza Virus Rapid Test Kits Market Size, 2017-2032 (USD Million)
  • TABLE 219. China Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 220. China Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 221. China Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 222. China Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 223. China Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 224. China Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 225. India Parainfluenza Virus Rapid Test Kits Market Size, 2017-2032 (USD Million)
  • TABLE 226. India Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 227. India Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 228. India Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 229. India Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 230. India Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 231. India Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 232. Japan Parainfluenza Virus Rapid Test Kits Market Size, 2017-2032 (USD Million)
  • TABLE 233. Japan Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 234. Japan Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 235. Japan Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 236. Japan Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 237. Japan Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 238. Japan Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 239. Australia Parainfluenza Virus Rapid Test Kits Market Size, 2017-2032 (USD Million)
  • TABLE 240. Australia Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 241. Australia Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 242. Australia Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 243. Australia Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 244. Australia Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 245. Australia Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 246. South Korea Parainfluenza Virus Rapid Test Kits Market Size, 2017-2032 (USD Million)
  • TABLE 247. South Korea Parainfluenza Virus Rapid Test Kits Market Size, by Test Method, 2017-2032 (USD Million)
  • TABLE 248. South Korea Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Based, 2017-2032 (USD Million)
  • TABLE 249. South Korea Parainfluenza Virus Rapid Test Kits Market Size, by Instrument Free, 2017-2032 (USD Million)
  • TABLE 250. South Korea Parainfluenza Virus Rapid Test Kits Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 251. South Korea Parainfluenza Virus Rapid Test Kits Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 252. South Korea Parainfluenza Virus Rapid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 253. Global Parainfluenza Virus Rapid Test Kits Market Share, by Key Player, 2025
  • TABLE 254. Global Parainfluenza Virus Rapid Test Kits Market, Key Experts